Compare A & EL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | A | EL |
|---|---|---|
| Founded | 1999 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Package Goods/Cosmetics |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.8B | 41.5B |
| IPO Year | 1999 | 2007 |
| Metric | A | EL |
|---|---|---|
| Price | $118.92 | $98.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 22 |
| Target Price | ★ $162.31 | $103.05 |
| AVG Volume (30 Days) | 2.2M | ★ 4.6M |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | 0.86% | ★ 1.40% |
| EPS Growth | ★ 3.16 | N/A |
| EPS | ★ 4.57 | 0.57 |
| Revenue | $4,472,000,000.00 | ★ $14,326,000,000.00 |
| Revenue This Year | $8.03 | $7.66 |
| Revenue Next Year | $6.22 | $4.21 |
| P/E Ratio | ★ $25.82 | $176.11 |
| Revenue Growth | ★ 6.43 | N/A |
| 52 Week Low | $96.43 | $48.37 |
| 52 Week High | $160.27 | $121.64 |
| Indicator | A | EL |
|---|---|---|
| Relative Strength Index (RSI) | 31.10 | 35.38 |
| Support Level | $110.49 | $84.34 |
| Resistance Level | $123.79 | $119.31 |
| Average True Range (ATR) | 3.73 | 4.11 |
| MACD | -0.30 | -1.09 |
| Stochastic Oscillator | 29.10 | 18.50 |
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Estée Lauder is a leader in the global prestige beauty market, participating across skin care (49% of fiscal 2025 sales), makeup (29%), fragrance (17%), and hair care and others (5%). Top selling brands include Estée Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 31% of revenue from the Americas, 37% from Europe, the Middle East and Africa (including travel retail), and 32% from Asia-Pacific. Estée Lauder sells its products through department stores, travel retail, specialty multibrand beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.